Items where Author is "Nehzat, N."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 17.

(2022) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. pp. 21-27. ISSN 1432-0460 (Electronic) 0179-051X (Linking)

(2022) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. pp. 21-27. ISSN 0179-051x

(2022) Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorder. Current Journal of Neurology. pp. 206-210. ISSN 2717-011X

(2022) Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis. Psychol Health Med. pp. 1234-1244. ISSN 1354-8506

(2022) Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset. JOURNAL OF CLINICAL MEDICINE. ISSN 2077-0383 J9 - J CLIN MED

(2022) The prevalence of sexual dysfunction (SD) and erectile dysfunction (ED) in men with multiple sclerosis (MS): a systematic review and meta-analysis. Neurologia (Engl Ed). ISSN 2173-5808

(2021) Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder. Caspian Journal of Neurological Sciences. pp. 10-16. ISSN 23834307 (ISSN)

(2021) COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review. Neurol Neuroimmunol Neuroinflamm. ISSN 2332-7812

(2021) Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis. Neurol Res Int. p. 6679197. ISSN 2090-1852 (Print) 2090-1860

(2021) Early predictors of conversion to secondary progressive multiple sclerosis. Mult Scler Relat Disord. p. 103115. ISSN 2211-0348

(2021) Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis. Autoimmunity Reviews. ISSN 1568-9972

(2021) Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS). Multiple Sclerosis International. ISSN 2090-2654

(2021) Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage. Neurological Sciences. pp. 2615-2618. ISSN 1590-1874

(2021) Frequency of comorbidities in Neuromyelitis Optica spectrum disorder. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. ISSN 0179-051x

(2021) Prevalence of seizure/epilepsy in patients with multiple sclerosis: A systematic review and meta-analysis. International Journal of Preventive Medicine. ISSN 2008-7802

This list was generated on Sun Feb 23 14:58:59 2025 +0330.